$0.147500
-0.0024-1.60%
At Close: -
$0.146600
-0.0009-0.61%
After Hours: 7:59 PM EDT
15 minutes delayed
Tonix Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Tonix Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-16 | $-19.28 | $-7.20 | -167.8 % |
Mar 2024 | 2024-05-13 | $-5.76 | $-12.48 | 53.8 % |
Mar 2024 | 2024-04-01 | $-27.52 | $-52.48 | 47.6 % |
Sep 2023 | 2023-11-09 | $-58.56 | $-47.68 | -22.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-16 | $2.21M | $3.35M | -34.1 % |
Mar 2024 | 2024-05-13 | $2.48M | $3.80M | -34.7 % |
Mar 2024 | 2024-04-01 | $3.78M | $3.83M | -1.33 % |
Sep 2023 | 2023-11-09 | $3.99M | $5.80M | -31.2 % |
Tonix Pharmaceuticals (TNXP) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 16, 2024 for Q2.
The Actual EPS was $-19.28, which missed the estimate of $-7.20.
The Actual Revenue was $2.2M, which missed the estimate of $3.4M.
Browse earnings estimates, EPS, and revenue on all stocks.